 | AbbVie Inc. -- Moody's announces completion of a periodic review of ratings of AbbVie Inc.
finance.yahoo.com - February 16 at 5:10 AM |
 | AbbVie Is Too Risky Right Now
seekingalpha.com - February 14 at 3:10 PM |
 | AbbVie (ABBV) Earns Hold Rating from Barclays
www.americanbankingnews.com - February 14 at 7:55 AM |
| AbbVie (ABBV) is a Top Dividend Stock Right Now: Should You Buy?
finance.yahoo.com - February 13 at 3:15 PM |
| AbbVie Suffers Market Loss For Humira In Europe, But The U.S. Is A Different Story
seekingalpha.com - February 12 at 5:04 AM |
| AbbVie on go to start clinical development of Parkinson's candidate ABBV-0805
seekingalpha.com - February 11 at 3:10 PM |
| Here's Why Coherus BioSciences Rose 48.7% in January
finance.yahoo.com - February 11 at 3:10 PM |
| AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma
finance.yahoo.com - February 11 at 9:51 AM |
 | Here's Why AbbVie's Stock Tanked in January
www.fool.com - February 9 at 3:06 PM |
| Here's Why AbbVie's Stock Tanked in January
finance.yahoo.com - February 9 at 3:06 PM |
| $7.78 Billion in Sales Expected for AbbVie Inc (ABBV) This Quarter
www.americanbankingnews.com - February 9 at 2:14 AM |
| After Humira: AbbVie's Upa Vs. Gilead's Filgo
seekingalpha.com - February 8 at 3:05 PM |
| What Are the Key Growth Drivers for AbbVie in 2019?
finance.yahoo.com - February 8 at 3:05 PM |
| Does FedEx look good here? What's the deal with McKesson? Buy Abbvie?
finance.yahoo.com - February 8 at 3:05 PM |
| Is AbbVie or Celgene Expected to Report Faster Revenue Growth?
finance.yahoo.com - February 8 at 5:14 AM |
| Zacks: Brokerages Anticipate AbbVie Inc (ABBV) Will Announce Earnings of $2.04 Per Share
www.americanbankingnews.com - February 7 at 11:18 PM |
 | Testosterone Replacement Therapy Market 2019 Analysis by Top Manufacturers Endo International, AbbVie, Eli lilly, Pfizer, Bayer, and more...
www.marketwatch.com - February 7 at 5:08 AM |
| At least four pharma CEOs to testify at Senate drug pricing hearing
finance.yahoo.com - February 6 at 3:14 PM |
| Congress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Here's what they're saying
finance.yahoo.com - February 6 at 3:14 PM |
 | Johnson Fistel, LLP Announces Investigations of AbbVie Inc., Macquarie Infrastructure Corporation, OPKO Health, Inc. and Uxin Limited; Investors Encouraged to Contact Firm - PRNewswire
www.prnewswire.com - February 6 at 5:19 AM |
| Pharma execs will testify before Congress 'one way or another,' US senator says
finance.yahoo.com - February 5 at 3:15 PM |
| Merck CEO Frazier plans to testify at Senate drug pricing hearing
finance.yahoo.com - February 5 at 3:15 PM |
| Bulls & Bears Of The Week: AT&T, Facebook, GE, Microsoft And More
finance.yahoo.com - February 3 at 3:07 PM |
| Is AbbVie a Buy?
www.fool.com - February 3 at 9:50 AM |
| Pricing Pressure a Hard Pill for Pharma to Swallow
finance.yahoo.com - February 2 at 5:09 AM |
| The Zacks Analyst Blog Highlights: Union Pacific, AbbVie and General Dynamics
finance.yahoo.com - February 1 at 3:13 PM |
| Top Research Reports for Union Pacific, AbbVie & General Dynamics
finance.yahoo.com - January 31 at 3:08 PM |
| AbbVie's Existential Tests Are Upon It
seekingalpha.com - January 31 at 5:07 AM |
| A Look at AbbVie’s Diversified Product Portfolio in Fiscal 2019
finance.yahoo.com - January 30 at 3:10 PM |
| 3 Big Pharmas Expecting a Softer 2019
finance.yahoo.com - January 30 at 3:10 PM |
| AbbVie Reports Improvement in Margins in Fiscal 2018
finance.yahoo.com - January 30 at 3:10 PM |
| Genentech kills big drug study in early Alzheimer's patients
finance.yahoo.com - January 30 at 3:10 PM |
| AbbVie (ABBV) Price Target Cut to $8.67 by Analysts at Argus
www.americanbankingnews.com - January 30 at 8:33 AM |
| William Blair Weighs in on AbbVie Inc's Q1 2019 Earnings (ABBV)
www.americanbankingnews.com - January 30 at 7:12 AM |
 | Cramer's lightning round: AbbVie needs to make an acquisition—it might just save its stock
www.cnbc.com - January 29 at 7:13 PM |
| Imbruvica Is Key Growth Driver for AbbVie in Fiscal 2019
finance.yahoo.com - January 29 at 3:07 PM |
| Jacksonville's increasing use of LNG as a transportation fuel
finance.yahoo.com - January 29 at 3:07 PM |
| Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y
finance.yahoo.com - January 29 at 3:07 PM |
| Brokers Issue Forecasts for AbbVie Inc's Q1 2020 Earnings (ABBV)
www.americanbankingnews.com - January 29 at 8:24 AM |
| AbbVie: Tough 2019 Ahead
seekingalpha.com - January 29 at 5:10 AM |
| AbbVie Missed Revenue Estimates in Q4 2018
finance.yahoo.com - January 29 at 5:10 AM |
| Analysts Cut AbbVie Price Targets After Earnings Miss
finance.yahoo.com - January 28 at 3:00 PM |
| 3 Reasons I Just Tripled Down On AbbVie
seekingalpha.com - January 28 at 5:16 AM |
| Edited Transcript of ABBV earnings conference call or presentation 25-Jan-19 2:00pm GMT
finance.yahoo.com - January 28 at 5:16 AM |
| 3 Reasons AbbVie Investors Aren't Too Worried About Humira Anymore
finance.yahoo.com - January 28 at 5:16 AM |
| Q1 2019 EPS Estimates for AbbVie Inc Cut by Piper Jaffray Companies (ABBV)
www.americanbankingnews.com - January 28 at 2:16 AM |
| Credit Suisse Group Reiterates $79.00 Price Target for AbbVie (ABBV)
www.americanbankingnews.com - January 27 at 11:46 PM |
| 3 Reasons AbbVie Investors Aren't Too Worried About Humira Anymore
www.fool.com - January 27 at 7:35 PM |
| AbbVie: Not Driving Via The Rearview Mirror
seekingalpha.com - January 27 at 3:14 PM |
| Forget Humira -- Here's What You Need to Know About AbbVie
finance.yahoo.com - January 27 at 3:14 PM |
